29th Annual Meeting and Education Day of the Society for Neuro-Oncology (SNO)

Friday, November 22

7:45–7:55 a.m., CT (located in Grand Assembly C)

• Oral Abstract Session: The increased risk of meningioma among individuals who are non-Hispanic Black is magnified among males and among those diagnosed with grade 2-3 tumors

7:55–8:05 a.m., CT (located in Grand Assembly C)

• Oral Abstract Session: Genomic ancestry-related risk ratios for glioblastoma incidence among global populations and racial/ethnic groups within the United States

7:30–9:30 p.m., CT (located in Hall B3)

• Poster: Sex differences in lung cancer brain metastases adverse events (DISP-04)
• Poster: The impact of social determinants of health on treatment delays for glioblastoma (DISP-06)
• Poster: History of type III immune hypersensitivity improves survival in glioblastoma (EPID-23)
• Poster: Spatial transcriptomics enables statistical modeling of sex difference in gene co-expression network and immune landscape of glioblastoma (EPCO-44)

Saturday, November 23, 3:45–5:15 p.m., CT (located in Grand Ballroom A)

• Panel: Statistics, sexual health and fertility, and special considerations in sexual and gender diverse AYA populations

Sunday, November 24, 10:15–11:45 a.m., CT (located in Grand Assembly C)

• Oral Abstract Session: Multi-institutional validation of an AI-based model for prediction of tumor infiltration and future recurrence in patients with glioblastoma: results from the ReSPOND consortium